BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28097792)

  • 1. FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.
    Barrett R; Morash B; Roback D; Pambrun C; Marfleet L; Ketterling RP; Harrison K; Berman JN
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
    Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
    Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia.
    Panagopoulos I; Torkildsen S; Gorunova L; Tierens A; Tjønnfjord GE; Heim S
    PLoS One; 2014; 9(5):e96570. PubMed ID: 24798186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
    Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
    Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.
    Daifu T; Kato I; Kozuki K; Umeda K; Hiramatsu H; Watanabe K; Kamiya I; Taki T; Nakahata T; Heike T; Adachi S
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e325-7. PubMed ID: 24390445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
    Schmidt HH
    Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
    [No Abstract]   [Full Text] [Related]  

  • 8. t(8;16)(p11;p13) predisposes to a transient but potentially recurring neonatal leukemia.
    Wong KF; Yuen HL; Siu LL; Pang A; Kwong YL
    Hum Pathol; 2008 Nov; 39(11):1702-7. PubMed ID: 18657848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous remission of congenital acute myeloid leukemia with t(8;16)(p11;13).
    Wu X; Sulavik D; Roulston D; Lim MS
    Pediatr Blood Cancer; 2011 Feb; 56(2):331-2. PubMed ID: 21157904
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a
    Panagopoulos I; Andersen K; Ramslien LF; Ikonomou IM; Micci F; Heim S
    Anticancer Res; 2021 Apr; 41(4):1753-1760. PubMed ID: 33813379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.
    Vizmanos JL; Larráyoz MJ; Lahortiga I; Floristán F; Alvarez C; Odero MD; Novo FJ; Calasanz MJ
    Genes Chromosomes Cancer; 2003 Apr; 36(4):402-5. PubMed ID: 12619164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t(8;19)(p11;q13).
    Chinen Y; Taki T; Tsutsumi Y; Kobayashi S; Matsumoto Y; Sakamoto N; Kuroda J; Horiike S; Nishida K; Ohno H; Uike N; Taniwaki M
    Genes Chromosomes Cancer; 2014 Apr; 53(4):299-308. PubMed ID: 24446090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
    Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
    Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Long-term Survivor after Congenital Acute Myeloid Leukemia with t(8 ; 16)(p11 ; p13).
    Hanada T; Kanamitsu K; Chayama K; Miyamura T; Kanazawa Y; Muraoka M; Washio K; Imada M; Kageyama M; Takeuchi A; Tamai K; Oda M; Shimada A
    Acta Med Okayama; 2016; 70(1):31-5. PubMed ID: 26899607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
    Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ
    Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
    Ananthaneni A; Benzar T; Hafiz N; Akabane H
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia.
    Ma ESK; Wan TSK; Au CH; Ho DN; Ma SY; Ng MHL; Chan TL
    Cancer Genet; 2017 Dec; 218-219():15-19. PubMed ID: 29153093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
    Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
    J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.